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ABSTRACT: In this study, 254 Escherichia coli isolates from faecal samples of veal calves were evaluated for 
antimicrobial susceptibility using the disk diffusion method. During the experimental period, six mass antibi-
otic treatments were administered to the animals (about one treatment per month). The active principles used 
were oxytetracycline, colistin, tylosin, doxycycline, chlortetracycline, and sulphonamides. An extremely high 
resistance prevalence (> 70%) towards penicillin, sulphonamide, tetracycline, ampicillin, and spyramicin was 
detected. Sixty E. coli isolates could be defined as multiresistant, showing resistance to at least 6 antimicrobial 
classes. Subsequently, we evaluated the inhibitory effect of a species-specific probiotic against multiresistant 
E. coli, showing its beneficial action with large inhibition halos for 76% of the isolates. This suggests the poten-
tiality of the probiotic, putting in evidence a clear advantage of its use in veal calves nutrition, in particular 
during the first phases, when the animals are more susceptible to severe enteric infections by E. coli.
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The repeated exposure to antimicrobials is con-
sidered a critical factor for the observed increase in 
resistance frequency of the commensal microflora 
in both animals and humans (van den Boogard 
and Stobberingh, 2000). Carriage of resistance 
genes by commensals has been proposed as an 
indicator of antibiotic resistance in a population, 
and its decrease should be regarded as a suitable 
public health goal (van den Boogard, 1997). In 
fact, intestinal commensal microflora acts as a 
potential reservoir of resistance genes that may 
be transferred to pathogenic bacteria inside the 
host. The diffusion of antimicrobial resistance 
among pathogens, that has been evidenced since the 
seventies, has resulted in a compromised efficacy 
of antimicrobial agents used in the treatment of 
infectious diseases, and is actually considered an 
emerging and serious public health concern (van 
den Boogard and Stobberingh, 2000; Martinez and 
Baquero, 2002; Ramos et al., 2013). In particular, 
the possibility of transferring antibiotic-resistant 
bacteria from food animals to humans through 
the consumption of meat or other animal prod-
ucts, by the contact with farm wastewater, and 
other ways must be regarded as a worldwide issue 
(Sàenz et al., 2004; Marshall and Levy, 2011). It is 
evident that resistance resulting from the use of 
antimicrobial agents in food-producing animals 
may have adverse human health consequences, 
with a potential increase in morbidity and mor-
tality from bacterial infections. A relationship 
between the use of antibiotics in food animals and 
antimicrobial resistance among bacteria isolated 
from humans is reported for Salmonella spp. and 
Campylobacter spp., but it has been described for 
other bacteria, and represents an item of increasing 
importance for some potential pathogens such as 
enterococci, Staphylococcus aureus, and especially 
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Escherichia coli (Barza, 2002; Swartz, 2002; Lee, 
2003; Angulo et al., 2004; Tollefson and Karp, 
2004). E. coli is a commensal bacterium living in 
the intestine of humans and animals, including 
food animals, but it is strongly considered for its 
potential pathogenicity for consumers. Since the 
early 1980s some serotypes (especially O157:H7) 
have caused several foodborne human infections 
(outbreaks or sporadic cases), in particular by 
the consumption of minced/comminuted beef 
(Pennington, 1998; Williams et al., 2000). Cattle 
are the major reservoir of this pathogen that is 
carried asymptomatically and excreted from the 
gastrointestinal tract. During cattle slaughter-
ing, faeces and hides are considered the main 
sources of E. coli; carcass contamination can oc-
cur during dressing phases, especially skinning 
and evisceration (Chapman et al., 2001; Aslam et 
al., 2003; Carney et al., 2006; Nastasijevic et al., 
2009). E. coli is able to acquire resistance genes 
from other microorganisms or from the environ-
ment, and can represent a potential reservoir 
for the horizontal transmission of these genes to 
different bacterial species occurring in the food 
chain (Trobos et al., 2008; Ahmed et al., 2009; 
Marshall and Levy, 2011; EFSA-ECDC, 2012). 
The resistance in these organisms is considered a 
good indicator of the selective pressure resulting 
from antimicrobial use in target populations (van 
den Boogard and Stobberingh, 2000). Recently, a 
report issued by EARSS (European Antimicro-
bial Resistance Surveillance System) dealt with 
antimicrobial resistance of E. coli and S. aureus 
population in the European Union, showing, dur-
ing the period 2002–2009, a decreasing trend in 
antibiotic susceptibility especially for E. coli, that 
was associated with a significant increase in human 
septicemic infections, reaching levels of concern. 
Infections caused by such antimicrobial-resistant 
strains are becoming common worldwide and are 
posing serious health problems for human medi-
cine (EARSS, 2008; ECDC, 2011).
The need for a reduction in antimicrobial use in 
animal breeding has encouraged, during last years, 
the interest for alternative methods to improve gut 
health and animal performances; in this context, 
the use of probiotics as feed additives seems to be 
very promising (Timmerman et al., 2005; Bakhshi 
et al., 2006; Frizzo et al., 2010; Kawakami et al., 
2010; Morrison et al., 2010; Riddell et al., 2010). 
In particular, the administration of multistrain 
and multispecies probiotics showed to be more 
effective than that of monostrain probiotics; a 
better capability of colonizing the gastrointestinal 
tract was demonstrated, associated with a syner-
gic activity due to the combination of different 
mechanisms of action (Timmerman et al., 2004; 
Soto et al., 2010).
In a previous work, functional aspects of lactic acid 
bacteria isolated from faecal samples of veal calves 
were evaluated for a potential probiotic use, design-
ing a multispecies multistrain formulate composed 
of Lactobacillus animalis-Lactobacillus paracasei 
subsp. paracasei-Bacillus coagulans (30 : 35 : 35). 
The same was then successfully tested for in vitro 
antimicrobial activity towards different potentially 
pathogenic bacteria (Ripamonti et al., 2009; 2011).
The aim of this study was to evaluate the preva-
lence of antibiotic resistance among E. coli isolates 
from the faeces of veal calves and to investigate 
the inhibitory effect of our probiotic formulate 
against the most resistant strains.
MATERIAL AND METHODS
Design of the experiment
Faecal samples were obtained from 24 veal calves, 
bred in multiple boxes of six animals each on slotted 
floor and fed a standard milk replacer/concentrate 
diet. During the trial three different milk replacers 
(on dry matter basis) were used from the arrival to the 
farm: Elite Start FE at days 0–14 (22% crude protein, 
18% crude fat), Elite 20 at days 15–100 (19% crude 
protein, 17% crude fat), and Elite 100 at days 101–180 
(20% crude protein, 18.5% crude fat) (Zoogamma 
s.p.a, Ghedi, Italy) with a mean reconstitution rate 
of 130 g/l and supplied at a temperature of 37°C. 
Calves were fed an increasing amounts of a com-
mercial concentrate Fibravit Wet Mais (Zoogamma 
s.p.a, Ghedi, Italy) on dry matter basis (13.20% crude 
protein, 4.41% crude fat, 4.25% crude fibre, 4.25% 
ash) starting from 100 g per head/day until 750 g 
per head/day at the end of the trial.
During the experimental period, six mass antibi-
otic treatments were administered to the animals 
(about one treatment each month was administered 
to veal calves, the first one performed at the ar-
rival to the farm): the active principles used were 
oxytetracycline (25 mg/kg body weight (BW)), 
colistin (50 mg/kg BW), tylosin (40 mg/kg BW), 
doxycycline (10 mg/kg BW), chlortetracycline 
(25 mg/kg BW), and sulfadimethoxine (25 mg/kg  
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BW). Monthly, faecal samples were collected from 
each calf upon rectal stimulation, stored in vials 
with transport medium (FecalTM Enteric Plus; Oxoid, 
Basingstoke, UK), and kept refrigerated at 4°C until 
the analyses, which were performed the same day. 
Sampling period started from 15 days of life of veal 
calves (T0) and lasted for 180 days (T5) in order 
to monitor the whole breeding cycle. Four faecal 
pools coming from 6 animals each were subjected 
to microbiological analysis. 10 g of each pool were 
diluted with 90 ml of Buffered Peptone Water (Ox-
oid) and homogenized in a Seward Stomacher 400 
Lab Blender Mixed Homogenizer (International 
PBI, Milano, Italy) for 1 min. Serial 10-fold dilu-
tions were plated onto TBX agar (Oxoid) for the 
enumeration of Escherichia coli, according to ISO 
16649-2:2001 method.
Isolation of Escherichia coli and evaluation 
of antibiotic susceptibility
A total of 254 E. coli colonies grown on TBX plates 
from faecal samples were randomly selected and 
subcultured in Tryptic Soy Broth (TSB) (Oxoid, 
Basingstoke, UK). The standard CLSI disk diffusion 
test was performed on each isolate (CLSI, 2007) us-
ing Tryptic Soy Agar (TSA) (Oxoid). Eight different 
classes of antimicrobial agents were chosen for the 
test: penicillins (penicillin G 10 IU, ampicillin 10 µg), 
sulphonamide 300 µg, cephalosporins (cephalothin 
30 µg), tetracyclines (tetracycline 30 µg), aminoglyco-
sides (neomycin 30 µg, apramycin 15 µg), macrolides 
(spyramicin 100 µg), lincosamides (lincomycin-
spectinomycin 109 µg), and quinolones (nalidixic 
acid 30 µg, enrofloxacin 5 µg). Negative control was 
performed using blank disks. The diameters of the 
inhibition zones were measured and the results (an 
average of 5 readings) were recorded and compared 
to the breakpoint value indicated by CLSI (2005), 
SFM (2011), and EUCAST (2012).
Inhibition of Escherichia coli by the probiotic
For the evaluation of the inhibitory effect on 
multiresistant E. coli strains, the species-specific 
probiotic was inoculated into MRS broth and grown 
anaerobically at 37°C for 48 h. After incubation, 
the broth was spread by a sterile swab onto the 
surface of MRS agar plates, subsequently incubated 
for 48 h at 30°C in an anaerobic jar (Anaerojar; 
Oxoid, Basingstoke, UK). Multiresistant E. coli 
isolates were selected by the test described above; 
the requisite for the selection was the resistance 
to penicillins, sulphonamide, tetracycline, and 
macrolides and to two of the other antimicrobial 
classes tested. These isolates were then subcultured 
aerobically overnight at 37°C in 10 ml of TSB. For 
each E. coli isolate, 0.2 ml of bacterial suspen-
sion (approximately 107 UFC/ml) were added to a 
5 ml share of semisolid agar (BHI broth (Oxoid) + 
agar 0.7%), maintained in a water bath (45°C) and 
then poured over the plates inoculated with the 
probiotic. After aerobic incubation at 37°C for 
24 h, the plates were checked. If E. coli growth 
was inhibited, a clear zone was observed around 
the probiotic colonies. Lactobacillus acidophilus 
ATCC 4356 was used as a negative control; the 
size of no-growth zones, when compared with 
those produced by the control strain, indicated the 
susceptibility, as reported by Rebucci et al. (2007).
RESULTS AND DISCUSSION
E. coli counts
In the present study the prevalence of antibiotic 
resistance of E. coli isolates from veal calves was 
evaluated. Among food-producing animals, calves 
can be considered a good indicator of antimicro-
bial resistance diffusion, as they are frequently 
submitted to mass and individual treatments to 
prevent the effects of bacterial infections. It is 
widely recognized that resistance due to the use of 
antimicrobial agents in animal breeding represents 
an emerging threat for human health. The results 
of microbial counts obtained from faecal samples 
are shown in Table 1. E. coli number in faecal 
samples increased during the first period, reaching 
at T1 a plateau level (6.5–7 Log CFU/g) that was 
maintained until the end of the experimental time 
(T5). It has to be noted that the administration of 
Table 1. Microbial counts of Escherichia coli obtained from faecal samples (mean values of 4 pools of 6 animals each)
  T0 T1 T2 T3 T4 T5
Log CFU/g faeces ± DS 4.16 ± 0.28 6.66 ± 0.28 6.86 ± 0.28 6.86 ± 0.25 6.86 ± 0.25 6.79 ± 0.25
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mass antibiotic treatments to calves did not result 
in any decrease in the concentration of E. coli, 
suggesting the possibility of a high prevalence of 
antimicrobial resistant strains in gut population.
Antimicrobial susceptibility of Escherichia coli
The investigation on E. coli isolates confirmed 
the hypothesis of a high prevalence of antibiotic 
resistance among bacterial population, evidenc-
ing the diffusion of multi-resistant strains. The 
results of antimicrobial susceptibility tests are 
reported in Table 2. According to the levels settled 
by EFSA-ECDC (2012) to describe the antimicrobial 
resistance, the frequency of resistance of E. coli 
population analyzed could be defined as extremely 
high (> 70%) towards penicillin, sulphonamide, 
tetracycline, ampicillin, and spyramicin, but high 
resistance frequencies (20–50%) were detected also 
for the other antibiotic classes, such as neomycin, 
cephalothin, spectinomycin, and nalidixic acid. Our 
results confirmed the data obtained in previous 
studies: Bradford et al. (1999) observed high resist-
ance frequencies in E. coli strains isolated from 
calves, in particular towards ampicillin (100%), 
kanamycin, streptomycin, and tetracycline. In 
another study performed on 120 strains of E. coli, 
Güler et al. (2008) found a high rate of resistance 
towards cephalothin (72%), followed by kanamycin 
(69.3%), tetracycline (69.3%), ampicillin (65.3%), 
trimethoprim (52%), and gentamicin (24%). Similar 
rates were detected also by Hariharan et al. (2004) 
in E. coli strains isolated from calves (81% against 
oxytetracycline and 64% against neomycin) and 
by Werckenthin et al. (2002), who found resist-
ance rates over 80% for tetracyclines, ampicil-
lin, sulphonamide/trimethoprim combination, 
and chloramphenicol. A recent report published 
by EFSA-ECDC (2012) underlined the common 
presence of resistance in E. coli strains isolated 
from fowl, pigs, cattle, and food to tetracyclines, 
ampicillin, and sulphonamides, whereas resistance 
to third-generation cephalosporins and fluoroqui-
nolones remained low. In our trial, a significant 
rate of multiresistance was detected: 60 E. coli 
isolates could be defined as multiresistant (23.6% 
of the total tested isolates), showing resistance to 
at least 6 antimicrobial classes, and 4% of tested 
strains were resistant to all of the 11 antimicrobials 
considered, confirming the growing diffusion of 
this phenomenon in Italy (ECDC, 2011).
Inhibition of Escherichia coli  
by the probiotic formulate
The present evaluation of the functionality of the 
species-specific probiotic formulation showed its 
ability to inhibit the growth of our multiresistant 
E. coli. The results of the inhibition test against each 
of the 60 multidrug-resistant E. coli are given in 
Table 3. The probiotic showed an inhibitory effect 
towards all the isolates tested: 76.7% of the strains 
showed a clear zone ≥ 20 mm (Figure 1), 20.0% 
between 10 and 20 mm, and 3.3% a zone < 10 mm. Table 2. Antimicrobial susceptibility of Escherichia coli isolates
Antimicrobial agents Limit halo (mm)
Number of 
resistant/total (%)
Penicillina 10 IU < 18 249/254 97.88
Sulphonamidea 300 µg < 12 242/254 95.30
Tetracyclinea 30 µg ≤ 17 236/254 92.91
Ampicillinb 10 µg ≤ 14 230/254 90.70
Spyramicina 100 µg ≤ 19 212/254 83.47
Neomycina 30 µg ≤ 15 123/254 48.33
Cephalotina 30 µg ≤ 18 108/254 42.52
Nalidixic acida 30 µg ≤ 15 89/254 35.18
Lincomycin-Specti-
nomycina 109 µg < 20 84/254 33.05
Apramycinc  15 µg < 18 50/254 19.55
Enrofloxacina 5 µg ≤ 30 45/254 17.70
aSFM (2011), bEUCAST (2012), cCLSI (2005)
Figure 1. Representative figure of the inhibitory action of 
the probiotic against a multiresistant E. coli isolate
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This activity could be due to different mechanisms, 
the most likely being the production of organic 
acids; in fact the production of propionic, acetic, 
and lactic acids by the strains included in the for-
mulate has been already observed during previous 
in vitro studies (Ripamonti et al., 2011). Further 
studies are needed to elucidate the behaviour of 
the probiotic strains in field trials, to confirm data 
obtained in vitro also in the presence of interfering 
factors such as breeding practices, feeding, and 
use of antibiotic treatments. 
CONCLUSION
The use of probiotics as a feeding strategy to 
contrast gut infections and to improve the func-
tionality of gastrointestinal tract has been widely 
applied in different species, especially in pigs and 
poultry (Ghareeb et al., 2012; Heo et al., 2013), 
but few products are actually used for veal calves. 
In this context, our study represents the first step 
for the perfection of a product that could enlarge 
the availability of means to contrast the prevalence 
of severe infections by E. coli strains that involve 
veal calves especially during the first phases of life.
The use of probiotics in animal nutrition rep-
resents an alternative and effective approach to 
antibiotic treatments leading to a reduction of 
breeding costs and joining current law requirements 
(Regulation (EC) No. 1831/2003) which focus on the 
priority of a limitation in the use of antimicrobials 
for the improvement of public health protection. 
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